Breaking bad news of cancer diagnosis - Perception of the cancer patients in a rural community in Malaysia [0.03%]
马来西亚农村社区癌症患者的不良告知感知——以癌症诊断为例
Mathew Gabriel Bain,Cheah Whye Lian,Chang Ching Thon
Mathew Gabriel Bain
Context: Breaking of bad news is an important component in the management of cancer patients. Aims: This study aimed to assess the perc...
Sushma Agrawal
Sushma Agrawal
Postoperative radiation therapy (RT) and chemotherapy,both reduces the risk of local recurrence and extends overall survival in patients with breast cancer (BC). Concerns have, however, been raised about the risk of acute and chronic side e...
Evaluation of protective effect of myricetin, a bioflavonoid in dimethyl benzanthracene-induced breast cancer in female Wistar rats [0.03%]
茋类致癌剂诱导的雌性大鼠乳腺癌中异鼠李素的抑癌作用研究
J K Jayakumar,P Nirmala,B A Praveen Kumar et al.
J K Jayakumar et al.
Background: Breast cancer is one of the most common cancers worldwide. Alarmingly, the incidence of breast cancer is rising rapidly in India. Aim: ...
Age at diagnosis of female breast cancer in Oman: Issues and implications [0.03%]
阿曼妇女乳腺癌的诊断年龄：问题及影响
Itrat Mehdi,Essam Abdul Monem,Bassim Jaffar Al Bahrani et al.
Itrat Mehdi et al.
Introduction: Female breast cancer (BC) is the most frequent malignancy diagnosed globally, about 23% of the diagnosed cancers. BC incidence varies geographically, highest in Western Europe and lowest in Africa. BC in fem...
Breast carcinoma in young females below the age of 40 years: A histopathological perspective [0.03%]
年轻女性乳腺癌的病理特征分析(低于40岁者)
Shitalmala Thangjam,Rajesh Singh Laishram,Kaushik Debnath
Shitalmala Thangjam
Background: Breast cancer among young women is a rare pathology, but is known to have a more aggressive behavior and poorer outcome. Aims: ...
Yasmin Khan
Yasmin Khan
Authors' reply [0.03%]
作者回复
Sudeep Gupta,Rajendra A Kerkar,Rajesh Dikshit et al.
Sudeep Gupta et al.
Joel Palefsky
Joel Palefsky
Lucy A Pickard,Graham Knee,Vishal Jayakar
Lucy A Pickard
Using 2(nd) generation tyrosine kinase inhibitors in frontline management of chronic phase chronic myeloid leukemia [0.03%]
二代酪氨酸激酶抑制剂一线治疗慢性期慢性粒细胞白血病中的应用
Vishal Jayakar
Vishal Jayakar
Choices in medicine come with responsibility. With several TKI's (Tyrosine kinase inhibitors) available for front-line management of CML (Chronic Myeloid Leukemia), an astute clinician has to personalise, rationalise and take a pragmatic ap...